7-hydroxy-3,4-dihydroquinolin-2(1H)-one; 7-Hydroxycarbostyril; 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone; 3,4-Dihydro-7-hydroxy-carbostyril; 7-Hydroxy-1,2,3,4-tetrahydro-2-quinolinone; Aripiprazole Impurity; Aripiprazole EP Impurity A
Aripiprazole EP Impurity A is a fully characterized chemical compound used as a reference standard of API Aripiprazole. The standard offered is compliant with regulatory guidelines. Aripiprazole EP Impurity A is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 22246-18-0
Related products
7-(but-3-en-1-yloxy)-3,4-dihydroquinolin-2(1H)-one
M.F.
M.W. 217.27
CAT# AR-A02520
CAS# 1359829-23-4
Aripiprazole Related Compound (OPC 14714) HCl
M.F.
M.W. 458.40 36.46
CAT# AR-A02524
CAS# 203395-84-0 (free base)
1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl-7-OH Carbostyril
![Picture of 1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl-7-OH Carbostyril](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-A02527.jpg?size=256 "Show details for 1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl-7-OH Carbostyril")
M.F.
M.W. 448.4
CAT# AR-A02527
CAS# 1797983-65-3
1-(but-3-en-1-yl)-4-(2,3-dichlorophenyl)piperazine
M.F.
M.W. 285.22
CAT# AR-A02532
CAS# 1424857-93-1
8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide
![Picture of 8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-A02543.jpg?size=256 "Show details for 8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide")
M.F.
M.W. 286.23 79.90
CAT# AR-A02543
CAS# 795313-24-5
Aripiprazole EP Impurity G (Aripiprazole Dimer Impurity)
M.F.
M.W. 922.81
CAT# AR-A02529
CAS# 1797986-18-5
